Home / Health / Weight-Loss Drugs Reshape UK Households
Weight-Loss Drugs Reshape UK Households
19 Nov
Summary
- 8.5% of Great Britain households now use weight-loss drugs.
- GLP-1 users collectively spent £1bn less on groceries.
- Male users of weight-loss drugs have nearly doubled.
Weight-loss medication usage has seen a substantial rise in Great Britain, with 8.5% of households reporting a user by August 2026, up from 6.3% in February. Approximately 2.6 million adults were taking these drugs, with pill formulations approved in June 2026 contributing to accessibility.
Male users have nearly doubled to 830,000, now comprising 32% of all users. This increased adoption impacts consumer habits, with households containing GLP-1 users collectively spending £1bn less on groceries than anticipated in the year after starting the medication.
Spending and volume on groceries have fallen proportionally, with indulgence and impulse items like alcohol and crisps seeing the largest decline. Conversely, portion-controlled meals and hot chocolate have seen increased sales, indicating a shift in purchasing behavior rather than a complete reduction in spending.
Experts predict this trend is a significant, long-term change, with GLP-1 usage potentially exceeding 10% of households by 2027, prompting retailers and manufacturers to reassess their strategies.